IL6 and cancer: We found that SHC1 was associated with abundant signaling pathways in pan-cancer, such as TNFA-NFKB, inflammatory response, IL6-JAK-STAT3, hypoxia, EMT, apical junction, and angiogenesis (Supplementary Figure 5D).